ClinicalTrials.govpublic full text
A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
pulmonary hypertension, interstitial lung disease, vascular diseases, cardiovascular diseases, fibrosis, ph, ild, 6 minute walk distance, mosliciguat, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 995406
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.